Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis
Crossref DOI link: https://doi.org/10.1186/s12991-017-0133-7
Published Online: 2017-02-10
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Correll, Christoph U.
Ng-Mak, Daisy S.
Stafkey-Mailey, Dana
Farrelly, Eileen
Rajagopalan, Krithika
Loebel, Antony
Funding for this research was provided by:
Sunovion Pharmaceuticals Inc.
